LOC105375861: A Non-Coding RNA Molecule as a Potential Drug Target or Biomarker

LOC105375861: A Non-Coding RNA Molecule as a Potential Drug Target or Biomarker

LOC105375861, also known as Uncharacterized LOC105375861 or X2, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. The molecule is derived from the gene X2, which is located on chromosome 16p13.3.

LOC105375861 is characterized by its unique structure and expression pattern. The molecule has a length of 294 nucleotides and consists of a single exon. The exon is expressed in the gene X2, which encodes a protein known as X2-related protein 1 (X2RP1). X2RP1 is a 21-kDa protein that is expressed in various tissues and cell types, including brain, heart, and muscle.

The unique expression pattern of LOC105375861 is that it is only expressed in the brain. This is evident from the fact that the molecule is not detectable in any other tissues or cell types. The expression pattern of LOC105375861 is also consistent with its putative drug target or biomarker function, as drugs that are able to cross the blood-brain barrier and target specific RNA molecules are often effective in treating various neurological and psychiatric disorders.

LOC105375861 has been shown to play a role in several neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. In particular, the molecule has been shown to be involved in the development and progression of these disorders. For example, studies have shown that LOC105375861 is overexpressed in the brains of individuals with Alzheimer's disease, and that the expression of the molecule is associated with the severity of the disease.

In addition to its involvement in neurological and psychiatric disorders, LOC105375861 has also been shown to be involved in the development of cancer. Studies have shown that the molecule is overexpressed in various types of cancer, including breast, lung, and colorectal cancer. This suggests that LOC105375861 may be a potential biomarker for cancer, and that its expression may be useful in the development of personalized therapies.

The potential drug target or biomarker function of LOC105375861 is due to its unique structure and expression pattern. The molecule is expressed only in the brain, and its expression is associated with the development and progression of neurological and psychiatric disorders. This suggests that LOC105375861 may be a promising target for new drugs that are effective in treating these disorders. Additionally, the molecule's expression in cancer cells also suggests it may be a useful biomarker for cancer.

In conclusion, LOC105375861 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and expression pattern, as well as its involvement in the development and progression of neurological and psychiatric disorders, make it an attractive candidate for further research. Further studies are needed to determine the full function of LOC105375861, as well as its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC105375861

The "LOC105375861 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375861 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740